China Pharma Holdings (CPHI) Reports Q3 Earnings of $0.08
Tweet Send to a FriendGet Alerts CPHI Hot Sheet
Price: $0.23 --0%
Revenue Growth %: -11.0%
Financial Fact:
Selling expenses: 812.05K
Today's EPS Names:
IHS, MEI, PIR, More
Revenue Growth %: -11.0%
Financial Fact:
Selling expenses: 812.05K
Today's EPS Names:
IHS, MEI, PIR, More
Trade CPHI Now!
China Pharma Holdings (NYSE: CPHI) reported Q3 EPS of $0.08, versus $0.14 reported last year. Revenue for the quarter came in at $20.99 million, versus $18.68 million reported last year.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
- Korn/Ferry Int'l (KFY) Tops Q4 EPS by 1c, Offers Q1 Guidance
- Pier 1 Imports, Inc. (PIR) Reports In-Line Q1 EPS; Guides FY14 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
